Insider Trading February 11, 2026

Badger Meter CEO Buys $502,985 of Stock as Company Posts Slight Q4 Miss

Kenneth Bockhorst purchases 3,300 shares amid mixed fourth-quarter results that pressured pre-market trading

By Leila Farooq BMI
Badger Meter CEO Buys $502,985 of Stock as Company Posts Slight Q4 Miss
BMI

Kenneth Bockhorst, Chairman, President & CEO of Badger Meter Inc (NYSE:BMI), bought 3,300 shares on February 10, 2026, at $152.42 per share for a total of approximately $502985, bringing his direct holdings to 40,013 shares. The transaction was disclosed on a Form 4 filed with the Securities and Exchange Commission. The company also reported fourth-quarter 2025 results with EPS of $1.14 and revenue of $220.7 million, both below analysts' expectations and contributing to a pre-market share decline before a partial rebound.

Key Points

  • Kenneth Bockhorst, Chairman, President & CEO of Badger Meter Inc (NYSE:BMI), acquired 3,300 shares of common stock on February 10, 2026, at $152.42 per share, totaling approximately $502985.
  • After the purchase, Bockhorst directly owns 40,013 shares of Badger Meter; the purchase was disclosed via a Form 4 filed with the SEC.
  • Badger Meter reported Q4 2025 results with EPS of $1.14 and revenue of $220.7 million, both below analysts' expectations, which contributed to a pre-market share decline before a partial recovery - impacting investors and equity market participants.

Kenneth Bockhorst, who serves as Chairman, President & CEO of Badger Meter Inc (NYSE:BMI), reported an insider purchase on a Form 4 filed with the Securities and Exchange Commission. The filing shows Bockhorst acquired 3,300 shares of common stock on February 10, 2026, at a price of $152.42 per share. The purchase totaled approximately $502985, and after the transaction he directly holds 40,013 shares of Badger Meter.

The Form 4 disclosure provides the concrete details of the transaction but does not include commentary from company leadership. The purchase is recorded in the filing as a direct acquisition by Bockhorst and updates his personal ownership stake in the company.

Separately, Badger Meter released its fourth-quarter 2025 financial results. The company reported diluted earnings per share of $1.14 for the quarter, narrowly missing analysts' consensus of $1.16. Revenue for the quarter was $220.7 million, below the expected $231.98 million. Those results were highlighted by market observers and were cited as drivers of a decline in pre-market trading activity on the announcement.

Following the initial reaction, shares of Badger Meter experienced a partial recovery later in trading. The company's latest quarterly performance - with earnings and revenue below analyst projections - has been noted as part of a broader set of recent updates that market participants are evaluating.

Investors and analysts remain attentive to both executive transactions and the company's reported financial metrics. The Form 4 filing documenting Bockhorst's purchase and the fourth-quarter results together provide data points that market participants can use when assessing the company's near-term outlook, though the filing itself does not explain intent or future plans.


Context and factual recap:

  • The insider purchase: 3,300 shares acquired on February 10, 2026, at $152.42 per share, totaling approximately $502985.
  • Post-transaction ownership: Bockhorst directly owns 40,013 shares of Badger Meter.
  • Quarterly results: Q4 2025 EPS of $1.14 (vs. $1.16 expected) and revenue of $220.7 million (vs. $231.98 million expected).
  • Market reaction: an initial decline in pre-market trading followed by a partial recovery.

The information above is drawn from the company's regulatory filing and the reported fourth-quarter results. The filing documents the executed insider purchase; the earnings release provides the financial figures that influenced market activity on the announcement.

Risks

  • Market sensitivity to quarterly results - the Q4 2025 EPS and revenue came in below expectations, which drove an immediate pre-market decline in the company's shares; equity investors face potential further volatility.
  • Insider purchase does not clarify broader business prospects - while the CEO bought additional shares, the Form 4 filing does not explain intent or signal that operational trends have changed, leaving uncertainty for shareholders.
  • Ongoing investor scrutiny - with earnings and revenue missing projections, analysts and market participants remain focused on subsequent updates, creating uncertainty for near-term stock performance.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026